Novartis Won’t Move Swiss Research Jobs, Jimenez Tells NZZ

Novartis AG (NOVN), which is investing $1 billion to build a research and development center in Shanghai, won’t move highly-qualified jobs away from Switzerland, Chief Executive Officer Joe Jimenez told NZZ am Sonntag.

The company wants to tap the “enormous supply of talent” in China, Jimenez told the newspaper in an interview.

To contact the reporters on this story: Elena Logutenkova in Zurich at elogutenkova@bloomberg.net

To contact the editors responsible for this story: Frank Connelly at fconnelly@bloomberg.net;